Drover James R, Morale Sarah E, Wang Yi-Zhong, Stager David R, Birch Eileen E
Retina Foundation of the Southwest, Dallas, Texas, USA.
Optom Vis Sci. 2010 Nov;87(11):E806-12. doi: 10.1097/OPX.0b013e3181f6fb5e.
Because vernier acuity seems to be limited by the visual cortex, it possesses excellent potential as a clinical/screening tool to detect amblyopia in infants and toddlers. Thus, we developed the vernier acuity cards specifically for this age group. We compared developmental data gathered using this new test and the Teller Acuity Cards. In addition, we compared the clinical/screening validity of the two tests by testing children old enough to complete optotype acuity testing (6.2 ± 2.5 years).
Vernier acuity and grating acuity were assessed in 98 children and 18 adults with normal vision (age range = 2.8 months to 35.8 years). The developmental time course of the two visual functions was compared. In addition, vernier acuity and grating acuity were measured in 43 children with amblyopia and 30 nonamblyopic children with an amblyogenic condition. Each child's grating acuity and vernier acuity were classified as normal/abnormal based on age-appropriate norms. These classifications were compared with amblyopia diagnoses by crowded HOTV or Early Treatment Diabetic Retinopathy Study (ETDRS) testing.
Vernier acuity and grating acuity follow different developmental time courses in normal infants and children. Vernier acuity is initially poorer than grating acuity but surpasses it by the age 5 years and is adult-like by the age 8 years. Compared with the Teller Acuity Cards, the vernier acuity cards yielded higher sensitivity (81 vs. 44%) and similar specificity (73 vs. 93%) and were more sensitive to all amblyopia subtypes/levels of severity.
The developmental time course of vernier acuity differed from that of grating acuity, implying that it is not mediated by the retina. Also, the impressive validity of the vernier acuity cards suggests that they are an effective tool for detecting amblyopia.
由于游标视力似乎受视皮层限制,它作为检测婴幼儿弱视的临床/筛查工具具有极大潜力。因此,我们专门为这个年龄组开发了游标视力卡片。我们比较了使用这种新测试和泰勒视力卡片收集的发育数据。此外,我们通过测试年龄足够大、能够完成视标视力测试的儿童(6.2±2.5岁),比较了这两种测试的临床/筛查有效性。
对98名儿童和18名视力正常的成年人(年龄范围 = 2.8个月至35.8岁)进行了游标视力和光栅视力评估。比较了这两种视觉功能的发育时间进程。此外,对43名弱视儿童和30名有弱视致病因素的非弱视儿童进行了游标视力和光栅视力测量。根据适合年龄的标准,将每个儿童的光栅视力和游标视力分类为正常/异常。将这些分类结果与通过拥挤的HOTV或糖尿病视网膜病变早期治疗研究(ETDRS)测试得出的弱视诊断结果进行比较。
在正常婴幼儿和儿童中,游标视力和光栅视力遵循不同的发育时间进程。游标视力最初比光栅视力差,但在5岁时超过光栅视力,到8岁时接近成人水平。与泰勒视力卡片相比,游标视力卡片具有更高的灵敏度(81%对44%)和相似的特异性(73%对93%),并且对所有弱视亚型/严重程度水平更敏感。
游标视力的发育时间进程与光栅视力不同,这意味着它不是由视网膜介导的。此外,游标视力卡片令人印象深刻的有效性表明它们是检测弱视的有效工具。